The Kiniksa Pharmaceuticals Ltd. Class A stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the ...

Microsoft plans to make Maia its primary AI inference system, with Maia 300 targeting greater computing output per megawatt ...

BP expects $3 billion–$4.5 billion in post-tax impairments, while stronger refining margins and lower net debt give its third ...

The alliance gives Stryker exclusive U.S. sales rights for Versius and an option for a future acquisition as it expands into ...

STERIS plans a mainly debt-funded purchase of surgical-safety supplier Xodus Medical, with an additional earnout of up to ...

Firmus has withdrawn its Australian listing and will seek private capital, putting the funding of its AI infrastructure ...

In general the index tends to have very controlled movements and with good liquidity the risk is considered very low in this index. During the last day, the index moved 778.89 points between high and ...

Nvidia and major technology partners are promoting common facility and grid requirements to simplify the infrastructure ...

IonQ’s proposed Elisity acquisition adds enterprise access-control software to its quantum-security portfolio. The price ...

The Nvidia-powered Surface Laptop Ultra arrives October 16, with a $5,999 developer desktop following in November as ...

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved ...

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $10.54 between high and low, or 4.21%. For the ...